Newsletters - May 2003

Newsletters - May 2003

Four new patent applications were submitted to the United States patent and trademark office in January- February 2003:

  1. Skin Care Compositions for Facilitating Depigmentation and Improvement in Skin Texture
    Ddescribes unique natural herbal extract compositions that effect skin smoothness, even out skin tone and reduce inflammation

  2. Analgesic, Anti-inflammatory and Anti-tumor Properties of Naturally Occurring Boswellic Acids and their Derivatives
    D describes newly discovered additional beneficial effects of boswellic acids that have been long recognized for their anti-inflammatory effects, and outlines processes to prepare derivatives with enhanced biological activity

  3. Natural Ethyl p-methoxycinnamate: Method of Manufacture and its Use in Cosmetic Preparations
    Describes processes to prepare natural from Zingiberaceae plants, such as Kaempferia galanga roots, and the novel use of this compound in anti-acne and other skin care preparations

  4. Process to improve the composition and accumulation of organic selenium compounds in Allium sativum Linn. (garlic) for nutritional supplementation
    Describes a novel enrichment process to achieve an unique, bioavailable composition of natural organic selenium compounds in garlic bulbs

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.